Mirati Therapeutics Inc
NASDAQ:MRTX
Mirati Therapeutics Inc
Total Other Income
Mirati Therapeutics Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mirati Therapeutics Inc
NASDAQ:MRTX
|
Total Other Income
$37.2m
|
CAGR 3-Years
543%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mirati Therapeutics Inc's Total Other Income?
Total Other Income
37.2m
USD
Based on the financial report for Sep 30, 2023, Mirati Therapeutics Inc's Total Other Income amounts to 37.2m USD.
What is Mirati Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
64%
Over the last year, the Total Other Income growth was 417%. The average annual Total Other Income growth rates for Mirati Therapeutics Inc have been 543% over the past three years , 64% over the past five years .